<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01928875</url>
  </required_header>
  <id_info>
    <org_study_id>123.04-2012-GES-0009</org_study_id>
    <nct_id>NCT01928875</nct_id>
  </id_info>
  <brief_title>Comparison of Adequacy of Anesthesia Monitoring With Standard Clinical Practice During Routine General Anesthesia</brief_title>
  <official_title>Comparison of Adequacy of Anesthesia Monitoring With Standard Clinical Practice During Routine General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate that using Surgical Pleth Index (SPI) and Entropy&#xD;
      in adjunct to other clinical information decreases the occurrence rate of inadequate&#xD;
      anesthesia events, bradycardia and hypotension in comparison to standard clinical practice&#xD;
      during anesthesia. Adequacy of Anesthesia (AoA) monitoring comprises the use of both Entropy&#xD;
      and SPI measurements. Adequacy of anesthesia will be monitored using non-invasive blood&#xD;
      pressure, blood oxygen saturation (SpO2), ECG, and neuromuscular transmission (NMT).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Actual">February 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of hemodynamic instability</measure>
    <time_frame>Participants will be followed for the duration of their surgery</time_frame>
    <description>Incidence of hemodynamic instability including hypertension, hypotension, tachycardia, and bradycardia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">496</enrollment>
  <condition>Surgical Procedure, Unspecified</condition>
  <arm_group>
    <arm_group_label>Adequacy of Anesthesia (AoA) Monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adequacy of Anesthesia monitoring with SPI and Entropy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine (Standard) Anesthesia Monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AoA Monitoring</intervention_name>
    <description>Monitoring with Entropy and SPI parameters during surgery</description>
    <arm_group_label>Adequacy of Anesthesia (AoA) Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Routine (Standard) Anesthesia Monitoring</intervention_name>
    <description>Standard of care monitoring</description>
    <arm_group_label>Routine (Standard) Anesthesia Monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to provide written informed consent&#xD;
&#xD;
          -  Age 18-80 years of age&#xD;
&#xD;
          -  Surgery that is expected to last at least 2 hours under general anesthesia with&#xD;
             endotracheal tube&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any subject that meets the definition of vulnerable subject as defined in ISO&#xD;
             14155:2011&#xD;
&#xD;
          -  Per ISO 14155:2011, a vulnerable subject is defined as an individual whose willingness&#xD;
             to volunteer in a clinical investigation could be unduly influenced by the&#xD;
             expectation, whether justified or not, of benefits associated with participation or of&#xD;
             retaliatory response from senior members of a hierarchy in case of refusal to&#xD;
             participate&#xD;
&#xD;
          -  Any subject with a cardiac pacemaker&#xD;
&#xD;
          -  Any subject with atrial fibrillation at the time of obtaining the baseline values&#xD;
&#xD;
          -  Any subject with more than 5 ventricular extra systoles/minute at the time of&#xD;
             obtaining the baseline values&#xD;
&#xD;
          -  Any subject who needs invasive blood pressure measurement&#xD;
&#xD;
          -  Any subject who show hemodynamics that would have qualified for being considered as a&#xD;
             sign of inadequate anesthesia already at baseline:&#xD;
&#xD;
          -  Mean blood pressure below 60 mmHg or above 100 mmHg&#xD;
&#xD;
          -  HR below 45 /min or above 100/min&#xD;
&#xD;
          -  Any subject with epidural anesthesia or analgesia during the surgery. Epidural&#xD;
             catheter may be placed pre-operatively, and used in the PACU, but not during the&#xD;
             surgery&#xD;
&#xD;
          -  Any subject having surgery that requires prone position&#xD;
&#xD;
          -  Any subject with very high body mass index (&gt;35) because of incompatibility with the&#xD;
             target controlled anesthesia models used&#xD;
&#xD;
          -  Any subject with known allergies to the specific anesthetic agents/ analgesic drugs&#xD;
             intended for use in their surgeries&#xD;
&#xD;
          -  Any subject with laryngeal mask airway&#xD;
&#xD;
          -  Any subject who requires neuromuscular blocking agent infusion&#xD;
&#xD;
          -  Any subject who is going to have major surgery with a high risk of extensive blood&#xD;
             loss&#xD;
&#xD;
          -  Any subject with known chronic use of opioids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Szeged</name>
      <address>
        <city>Szeged</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>August 19, 2013</study_first_submitted>
  <study_first_submitted_qc>August 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2013</study_first_posted>
  <last_update_submitted>April 28, 2017</last_update_submitted>
  <last_update_submitted_qc>April 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

